Varex Imaging (VREX) to Post Quarterly Earnings on Monday

Varex Imaging (NASDAQ:VREX) is anticipated to issue its Q3 2026 results after the market closes on Monday, August 10th. Analysts expect Varex Imaging to post earnings of $0.22 per share and revenue of $215.5040 million for the quarter. Varex Imaging has set its Q3 2026 guidance at 0.150-0.300 EPS. Investors are encouraged to explore the company’s upcoming Q3 2026 earning report for the latest details on the call scheduled for Monday, August 10, 2026 at 5:00 PM ET.

Varex Imaging (NASDAQ:VREX) last announced its earnings results on Thursday, May 7th. The company reported $0.21 earnings per share for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.01). The business had revenue of $216.00 million during the quarter, compared to analysts’ expectations of $216.92 million. Varex Imaging had a positive return on equity of 8.19% and a negative net margin of 9.64%. On average, analysts expect Varex Imaging to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Varex Imaging Price Performance

Shares of NASDAQ:VREX opened at $11.19 on Monday. The business has a fifty day moving average price of $10.56 and a two-hundred day moving average price of $11.56. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.20 and a quick ratio of 1.43. The company has a market capitalization of $471.10 million, a PE ratio of -5.59 and a beta of 0.89. Varex Imaging has a 1 year low of $6.76 and a 1 year high of $14.56.

Institutional Trading of Varex Imaging

A number of hedge funds have recently bought and sold shares of VREX. Quarry LP bought a new stake in shares of Varex Imaging in the 3rd quarter worth approximately $64,000. BNP Paribas Financial Markets boosted its position in Varex Imaging by 18.5% during the second quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock valued at $113,000 after buying an additional 2,036 shares during the period. Aquatic Capital Management LLC bought a new position in shares of Varex Imaging during the third quarter valued at about $117,000. Cerity Partners LLC bought a new stake in shares of Varex Imaging in the 2nd quarter valued at about $123,000. Finally, The Manufacturers Life Insurance Company boosted its holdings in Varex Imaging by 10.4% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 15,302 shares of the company’s stock valued at $133,000 after acquiring an additional 1,442 shares during the period.

Analyst Ratings Changes

Several research analysts have recently weighed in on VREX shares. Zacks Research downgraded Varex Imaging from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 27th. Weiss Ratings restated a “sell (d-)” rating on shares of Varex Imaging in a research report on Wednesday, June 24th. Finally, Wall Street Zen raised Varex Imaging from a “hold” rating to a “buy” rating in a research note on Saturday, July 4th. Two analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Varex Imaging currently has an average rating of “Hold” and an average price target of $16.17.

About Varex Imaging

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.